NIMBUS Biotechnology: Change to Business Board
NIMBUS biotechnology reported a change to the company's Supervisory Board. Professor Axel Kleemann, formerly executive board member of Asta Medica AG has been appointed as a new member and chairman of the Supervisory Board. Professor Thomas Bayerl, Dr. Rainer Strohmenger (Wellington Partners Venture Capital GmbH, Germany), Jack Griffin and Mario Ober (CFH, Germany) continue to be board members. Nimbus Biotechnology thanks Werner Zöllner (Seed GmbH, Germany) for his former work and support in this position.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.